Compare ALG & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALG | EVO |
|---|---|---|
| Founded | 1955 | 1993 |
| Country | United States | Germany |
| Employees | N/A | 4766 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 821.2M |
| IPO Year | 1996 | N/A |
| Metric | ALG | EVO |
|---|---|---|
| Price | $168.89 | $2.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $225.00 | $7.00 |
| AVG Volume (30 Days) | ★ 136.7K | 110.1K |
| Earning Date | 03-02-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.59 | N/A |
| Revenue | ★ $1,603,715,000.00 | N/A |
| Revenue This Year | $5.51 | N/A |
| Revenue Next Year | $3.96 | $7.13 |
| P/E Ratio | $19.69 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $156.30 | $2.31 |
| 52 Week High | $233.29 | $4.80 |
| Indicator | ALG | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 40.12 | 36.10 |
| Support Level | $168.24 | $2.31 |
| Resistance Level | $192.33 | $3.78 |
| Average True Range (ATR) | 5.65 | 0.08 |
| MACD | 0.29 | 0.01 |
| Stochastic Oscillator | 54.48 | 22.51 |
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial, and agricultural use. Its products include agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck-mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, snow removal equipment, etc. The company's reportable segments are Vegetation Management, which generates the maximum revenue, and Industrial Equipment. Geographically, the company generates maximum revenue from the United States, followed by Canada, France, the UK, Brazil, the Netherlands, and other regions.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.